Viewing StudyNCT00003847



Ignite Creation Date: 2024-05-05 @ 10:17 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00003847
Status: TERMINATED
Last Update Posted: 2013-09-05
First Post: 1999-11-01

Brief Title: VX-710 Doxorubicin and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer
Sponsor: Vertex Pharmaceuticals Incorporated
Organization: Vertex Pharmaceuticals Incorporated

Key Dates - Follows AllAPIJSON File Order

Start Date: 1998-12
Start Date Type: None
Primary Completion Date: 2001-02
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 1999-11-01
First Submit QC Date: June 15 2004
Study First Post Date: 2004-06-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-09-04
Last Update Post Date: 2013-09-05
Last Update Post Date Type: ESTIMATED